The government of Canada has announced an investment grant of up to $49 million in the Digital Health and Discovery Platform (DHDP), a network of partners that seeks to establish a cutting-edge Canada-wide health data platform. Through this new platform, researchers and doctors will work to accelerate the development of new and personalized treatments to help to find cures for diseases that affect Canadians. While the platform will initially focus on cancer, the plan is to expand to other areas
Read More
Biomarkers| Big Data| News, Analysis, Insights - HIT Consultant
FDA Grants Breakthrough Designation to RenalytixAI for AI-Enabled Diagnostic for Kidney Disease
RenalytixAI, a developer of artificial intelligence-enabled clinical diagnostics for kidney disease, today announced that it has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA), for its lead diagnostic, KidneyIntelX™. This is the first such designation for an AI-enabled diagnostic for kidney disease publicly announced by any company.FDA Breakthrough Devices Program OverviewThe FDA’s Breakthrough Devices Program is a voluntary program for certain
Read More
Sonde Health Nabs $16M to Commercialize Vocal Biomarker Device to Diagnose Diseases
Sonde Health, a Boston-based digital medicine company developing a vocal biomarker device to transform the way we monitor and diagnose our mental and physical health has raised $16 million in Series A funding. The round was led by M Ventures (the corporate venture capital arm of Merck KGaA, Darmstadt, Germany), with participation from MP Healthcare Venture Management, Inc. (the corporate venture capital arm of Mitsubishi Tanabe Pharma Corporation), Neoteny 4, LP, Canepa Healthcare, and founder
Read More
Amazon Alexa Is Now HIPAA-Eligible, What’s Next for Healthcare?
Big News, But Just The Beginning
These days, big news stories in healthcare are just as likely to come from large technology companies as from major healthcare institutions. Case in point: In early 2018, Amazon created a huge stir in the industry early by announcing a venture with JPMorgan and Berkshire Hathaway that promised to go after the “hungry tapeworm” that is the cost of healthcare in the
Read More
Mayo Clinic to Develop New Diagnostic Test Using Patients’ Breath to Detect Lung Cancer
Mayo Clinic Laboratories is teaming up with Breath Diagnostics to develop new clinical diagnostic tests that use patient breath samples to identify individual biomarkers that can predict a spectrum of diseases. The first collaboration will focus on a diagnostic test that detects lung cancer using patients' exhaled breath. Benefits of BiomarkersBiomarkers are measurable substances that help in predicting the severity of a disease or infection. Examples of a biomarker include an individual's pulse
Read More
4 Pillars of Value for AI in Medical Imaging
At ECR this year, there were over 25 independent software vendors (ISVs), many of them start-ups, showcasing artificial intelligence (AI) solutions for medical imaging within a dedicated space. Additionally, with established imaging vendors foraying into the AI space, what was once the hype is now in the early stages of market maturity, and, it appears, AI within medical imaging is here to stay.
The question has now shifted to what clinical value AI solutions can provide, rather than if AI is
Read More
8 Use Cases for Natural Language Processing (NLP) Technology in Healthcare
A look at natural language processing (NLP) technology's top potential use cases reveals how its destined to disrupt healthcare.It’s no secret that the big data wave had been building in healthcare for some time. What has somewhat remained a bit mysterious, however, is how innovators planned to stave the flood and make use of the sizeable data to help healthcare providers create efficiencies and improve outcomes. According to a recent Chilmark report, natural language processing (NLP) may be the
Read More
1DROP Raises $4.25M to Support Commercialization of Portable Medical Diagnostics Platform
1DROP, a life sciences startup developing and commercializing an easy to use laboratory quality, portable medical diagnostic testing platform has raised $4.25 million in Series A funding led by led by Christian Wildmoser (former partner CVC Capital Partners & Swiss Startup Group Investor). The round also included participation from private investors of the Swiss Startup Group including Dr. Hans-Peter Strebel (owner of On Your Marks), Beat Schillig (IFJ Institute for Young Entrepreneurs) and
Read More
Mayo Clinic Researchers Identify Blood-Based DNA Biomarker Panel
Researchers at Exact Sciences Corp. and Mayo Clinic announced significant progress toward developing a panel of novel, blood-based, DNA biomarkers that could accurately detect hepatocellular carcinoma (HCC), the most common cancer that originates in the liver. The researchers detailed their findings during a presentation today at Digestive Disease Week.Using DNA extracted from the blood samples of 244 people, including 95 diagnosed across all stages of HCC, 51 with cirrhosis, and 98 healthy
Read More
Genetic Material Once Considered Junk Actually Could Hold Key to Cancer Drug Response
Material left out of common processes for sequencing genetic material in cancer tumors may actually carry important information about why only some people respond to immunotherapy, possibly offering better insight than the type of material that is being sequenced, according to a study by Mount Sinai researchers published on April 3 in Cell Reports. Sequencing a type of genetic material in cancer tumors called messenger RNA has transformed personalized cancer therapy and revealed biomarkers for
Read More